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Original ArticleExercise mitigates sleep-loss-induced changes
in glucose tolerance, mitochondrial function,
sarcoplasmic protein synthesis, and diurnal
rhythmsNicholas J. Saner 1,2,*, Matthew J-C. Lee 1, Jujiao Kuang 1, Nathan W. Pitchford 1,3, Gregory D. Roach 4,
Andrew Garnham 1, Amanda J. Genders 1, Tanner Stokes 5, Elizabeth A. Schroder 6, Zhiguang Huo 7,
Karyn A. Esser 8, Stuart M. Phillips 5, David J. Bishop 1,**, Jonathan D. Bartlett 1ABSTRACT
Objective: Sleep loss has emerged as a risk factor for the development of impaired glucose tolerance. The mechanisms underpinning this
observation are unknown; however, both mitochondrial dysfunction and circadian misalignment have been proposed. Because exercise improves
glucose tolerance and mitochondrial function, and alters circadian rhythms, we investigated whether exercise may counteract the effects induced
by inadequate sleep.
Methods: To minimize between-group differences of baseline characteristics, 24 healthy young males were allocated into one of the three
experimental groups: a Normal Sleep (NS) group (8 h time in bed (TIB) per night, for five nights), a Sleep Restriction (SR) group (4 h TIB per night,
for five nights), and a Sleep Restriction and Exercise group (SRþEX) (4 h TIB per night, for five nights and three high-intensity interval exercise
(HIIE) sessions). Glucose tolerance, mitochondrial respiratory function, sarcoplasmic protein synthesis (SarcPS), and diurnal measures of pe-
ripheral skin temperature were assessed pre- and post-intervention.
Results: We report that the SR group had reduced glucose tolerance post-intervention (mean change  SD, P value, SR glucose AUC:
149  115 A.U., P ¼ 0.002), which was also associated with reductions in mitochondrial respiratory function (SR: -15.9  12.4 pmol
O2.s
1.mg1, P ¼ 0.001), a lower rate of SarcPS (FSR%/day SR: 1.11  0.25%, P < 0.001), and reduced amplitude of diurnal rhythms. These
effects were not observed when incorporating three sessions of HIIE during this period (SRþEX: glucose AUC 67 57, P¼ 0.239, mitochondrial
respiratory function: 0.6  11.8 pmol O2.s1.mg1, P ¼ 0.997, and SarcPS (FSR%/day): 1.77  0.22%, P ¼ 0.971).
Conclusions: A five-night period of sleep restriction leads to reductions in mitochondrial respiratory function, SarcPS, and amplitude of skin
temperature diurnal rhythms, with a concurrent reduction in glucose tolerance. We provide novel data demonstrating that these same detrimental
effects are not observed when HIIE is performed during the period of sleep restriction. These data therefore provide evidence in support of the use
of HIIE as an intervention to mitigate the detrimental physiological effects of sleep loss.
 2020 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Sleep; Mitochondria; Glucose tolerance; Circadian rhythms; Exercise1. INTRODUCTION
The detrimental effects of sleep loss on glucose tolerance are now well
established, and insufficient sleep is a risk factor for the development of
type 2 diabetes (T2D) [1]. In fact, sleep loss is comparable with other
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periods of sleep restriction, or reduced time in bed (TIB), typically with a
sleep opportunity of 4e5 h per night, cause significant reductions in a
range of indices related to glucose metabolism [2e5]. The severity of
this effect can be seen with only one night of either sleep restriction (4 h
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Original Articlesensitivity [6e9]. Despite these findings, there are limited data
explaining the physiological and molecular changes that underpin these
effects. As a large proportion of the population do not meet the current
sleep recommendations (7e9 h per night) [10,11], and inadequate
sleep is a consequence of many occupations [12,13], gaining a better
understanding of these mechanisms may help to tailor specific in-
terventions aimed at counteracting the detrimental effects of sleep loss.
The physiological mechanisms that underpin the impairment of
glucose tolerance following sleep restriction are likely multifactorial.
While not previously investigated in the context of sleep loss, the
development of insulin resistance has been associated with a reduc-
tion in mitochondrial content and impaired mitochondrial respiratory
function [14,15]. Furthermore, reductions in citrate synthase activity (a
surrogate marker for mitochondrial content [16]) and mitochondrial
respiratory function has also been reported in T2D patients, compared
to obese non-diabetics, suggesting a link between mitochondrial
changes and the development of insulin resistance and T2D [14,15].
Therefore, sleep-loss-induced reductions in glucose tolerance may, in
part, be a consequence of changes in mitochondrial content, function,
or the processes that regulate these properties, including mitochon-
drial dynamics and mitochondrial protein synthesis [17]. In support of
this, 120 h of sleep deprivation was associated with a 24% reduction in
citrate synthase activity in human skeletal muscle [18]. However, how
these results translate to the context of the sleep loss commonly
experienced in society, such as repeated nights of partial sleep loss,
has not been determined and remains a critical gap in the literature.
The detrimental effect of sleep loss on glucose metabolism may also
be associated with the misalignment of circadian rhythms [7,8]. One
night of sleep deprivation (commonly experienced by 20% of the
world’s population who perform shift-work) leads to a reduction in
glucose tolerance and concomitant alterations in the expression of
skeletal muscle clock genes (i.e., Bmal1 and Cry1 gene expression [7])
and the content of clock proteins (i.e., BMAL1) [8], which are known to
regulate circadian rhythms at a molecular level [19]. The functional
significance of disrupting the molecular clock has been shown in
genetic mouse models (i.e., Clock mutant mice and the Bmal1 KO
mouse), which display reduced glucose tolerance, mitochondrial res-
piratory function, and skeletal muscle contractile function [20,21].
However, the effect of sleep restriction on markers of diurnal rhythms
(e.g., skeletal muscle clock gene expression) and the potential impli-
cations of such changes have not previously been examined.
One approach to mitigate or ablate the impact of reduced sleep
duration on glucose tolerance is via exercise [17]. Regular endurance
exercise has been shown to exert beneficial effects on glycemic control
via the activation of the contraction-mediated (insulin independent)
glucose uptake signaling pathway [22]. High-intensity interval exercise
(HIIE) is a time-efficient format of endurance exercise and also a potent
stimulus for the induction of mitochondrial biogenesis [23], with in-
crease in sarcoplasmic and mitochondrial protein synthesis and
mitochondrial content and respiratory function, occurring concomi-
tantly with improvements in glucose tolerance [24e27]. This raises the
intriguing hypothesis that exercise may also be useful to combat sleep-
loss-induced impairments to glucose tolerance, which are not
necessarily reversed by a period of recovery sleep alone [28e30].
Furthermore, the same detrimental metabolic changes that occur in
response to circadian misalignment and altered expression of clock
genes may also be ameliorated by performing exercise [20,31,32].
Consequently, HIIE may mitigate the detrimental effects of sleep loss
on glucose metabolism by increasing mitochondrial content and
function and preventing changes in circadian rhythmicity [17].2 MOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. TAccordingly, the aim of this study was to investigate the effect of sleep
restriction on glucose tolerance, and to examine the underlying
physiological alterations that might contribute to these changes;
specifically, we examined changes in mitochondrial content and
function and diurnal rhythms. Furthermore, we examined the role of
exercise as an intervention to mitigate the detrimental effects of sleep
restriction. We hypothesized that sleep restriction would reduce
mitochondrial content and respiratory function and disrupt diurnal
rhythms, with a concomitant reduction in glucose tolerance, but that
performance of HIIE would ameliorate these effects.
2. STUDY METHODOLOGY
2.1. Ethics approval
All procedures involved conform to the standards set by the latest
revision of the Declaration of Helsinki (except for registration in a
database) and were approved by the Victoria University Human
Research Ethics Committee (HRE15-294).
2.2. Participants
Twenty-four healthy, recreationally active men, aged between 18 and
40 years of age, volunteered to participate. Eligible participants 1) were
not taking any medications, 2) were not performing shift-work (within
the previous three months), 3) had regular sleeping habits (6e9 h per
night) and no previously diagnosed sleep disorders, 4) had not travelled
overseas in the previous two months, and 5) had a body mass index
(BMI) between 19 and 30.
2.3. Study overview
Eligible participants attended the exercise physiology laboratory for
baseline anthropometric measurements (i.e., height and body mass),
and aerobic fitness testing (peak oxygen uptake [V_O2peak] and peak
aerobic power [ẆPeak]) that was performed to volitional exhaustion on
an electronically braked cycle ergometer (Excalibur, V2.0; Lode, Gro-
ningen, Netherlands) using an incremental ramp protocol (30 W/min).
One week prior to the intervention, a resting skeletal muscle biopsy
was obtained to determine baseline levels of deuterium oxide (D2O)
enrichment, and to assess basal mitochondrial respiratory function.
Following baseline testing, the participants were allocated via mini-
mization into one of the three experimental groups, in a counter-
balanced order, so as to minimize differences in between-group
baseline measures for age, BMI, habitual sleep duration, V_O2peak, and
mitochondrial respiratory function (Table 1).
The study consisted of an eight-night stay within a temperature-
controlled sleep laboratory. All groups completed two initial nights of
baseline sleep (8 h TIB from 23:00 h to 07:00 h), followed by a five-
night intervention period, during which the Normal Sleep (NS) group
spent 8 h TIB (23:00 h to 07:00 h), while both of the Sleep Restriction
(SR) and Sleep Restriction and Exercise (SRþEX) groups spent 4 h TIB
per night (03:00 h to 07:00 h). Between 23:00 h and 03:00 h, lighting
was dimmed to below 15 lux to reduce the effect of lighting on
circadian rhythms [33]. The SRþEX group also performed three ex-
ercise sessions during the intervention period on days 4, 5, and 6 at
10:00 h. Following the intervention period, all groups completed a final
night of ad libitum recovery sleep. Participants were monitored
throughout the protocol and provided with a standardized diet con-
sisting of fixed proportions (relative to body mass) of carbohydrates
(4.5 g.kg1.d1), protein (1.5 g.kg1.d1) and fat (1 g.kg1.d1). All
mealtimes (six throughout the day) were kept constant. An overview of
the study protocol is shown in Figure 1.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1 e Baseline characteristics of participants.
NS (n ¼ 8) SR (n ¼ 8) SRþEX (n ¼ 8) P Value
Age (y) 24  4 (20, 30) 25  5 (21, 32) 24  4 (18, 29) P¼0.754
Height (cm) 177  8 (169, 191) 179  6 (173, 191) 179  7 (172, 192) P¼0.534
Mass (kg) 78.7  13.3 (62.8, 96.9) 74.5  11.7 (63.8, 90.8) 80.2  9.5 (61.4, 89.5) P¼0.601
BMI 25.2  3.6 (20.3, 29.3) 23.3  3.0 (20.0, 28.4) 24.6  2.5 (20.8, 27.6) P¼0.468
V_O2peak (mL.kg
1.min1) 43.7  9.7 (36.1, 64.8) 47.2  6.7 (38.9, 56.9) 48.0  5.0 (41.2, 56.6) P¼0.486
Ẇpeak (W) 319  59 (196, 399) 330  44 (281, 415) 362  48 (263, 425) P¼0.242
Habitual sleep duration (h:min) 7:37  0:45 (6:36, 8:46) 7:08  0:44 (6:15, 8:30) 7:17  0:39 (6:18, 7:57) P¼0.422
Mitochondrial respiration (pmol.s1.mg tissue1) 78.9  17.7 (59.1, 113.7) 85.8  25.3 (60.0, 133.3) 83.4  19.7 (63.3, 122.0) P¼0.802
Values are mean  SD, values in brackets are minimum and maximum values for each characteristic. There were no significant differences between the three groups for any of the
baseline characteristics. NS e Normal Sleep, SR e Sleep Restriction, SRþEX e Sleep Restriction and Exercise, BMI e body mass index, Ẇpeak e peak power (W), mitochondrial
respiration e maximal ADP-stimulated oxidative phosphorylation with electron transfer via electron transfer flavoprotein, and complex 1 and 2, of the electron transport system (pre-
study muscle biopsy).2.4. Sleep and physical activity monitoring
Sleep was assessed for one week prior to and then throughout the study
using wrist-watch activity devices (Actiwatch 2, Philips Respironics,
Murrysville, PA, USA) [34]. Sleep architecture, duration, and quality were
also determined via polysomnography (PSG) (Compumedics, AUS) on
night 6 for a subset of participants from each condition (n ¼ 12; 4 per
group). Electrode placement for PSG monitoring was determined using
the 10e20 electrode placement system and scored in accordance to
standard criteria [35]. Habitual daily step counts were monitored using
validated step-counting applications on the participants’ personal mo-
bile phone devices (i-Health app, Apple Inc., Cupertino, CA, USA; and
Samsung Health, Samsung Electronics Co., Ltd., Suwon, South Korea)
and these step counts were replicated throughout the study
(Supplementary Table 1) (data modified from [36]).
2.5. High-intensity interval exercise (HIIE)
The HIIE protocol was adapted from previous studies, which demon-
strated improvements in glucose tolerance [27,37] and consisted ofFigure 1: Schematic representation of the study protocol. OGTT e oral glucose tolera
intensity interval exercise, R e ad libitum recovery sleep, PSG e polysomnography sleep m
habitual sleep and physical activity monitoring.
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Racer-Mate, Seattle, WA, USA) at 90% of each participant’s Ẇpeak.
Each interval was interspersed with 75 s of active recovery at 60 W.
Each session started with a 3-minute warm up at 60 W. The mean
power per interval was 318  53 W, and the mean HR throughout the
protocol was 156  13 bpm.
2.6. Wrist skin temperature measurements and circadian statistical
analysis
Wrist skin temperature was measured every 10 min at a sensitivity
of þ/ 0.0625 C across two 48-h periods (pre-intervention - Days 2
and 3 (until 11 pm) and post-intervention - Days 6 and 7), using non-
invasive temperature recording devices (iButtons, Thermochron iBut-
ton; Embedded Data Systems, Lawrenceburg, KY). This method has
been shown to be reliable and valid for evaluating temperature
circadian rhythmicity, with peripheral wrist skin temperature reported
to have an inverse relationship to core body temperature [38,39]. As
these measures were obtained under everyday life conditions, withnce test, GXT e graded exercise test, D2O e deuterium oxide ingestion, HIIE e high-
onitoring, participant screening refers to medical questionnaires, exclusion criteria, and
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
Original Articleregular meals and activity, they reflect diurnal rhythms, as opposed to
circadian rhythms.
The diurnal analysis of the skin temperature data for each individual
subject was performed with the 48 h of data for the pre- and post-
intervention days. The data were fit with the following sine wave curve:
yt ¼ Amp  sinðF ðt þ PhaseÞÞ þ Basal ;
where t (0  t  48 [hours]) was the circadian time, yt was the body
temperature at time t , and the frequency F was fixed at 24-h period.
Amp , Phase, and Basal were the amplitude, phase, and basal level of
the sine wave curve, respectively. The amplitude is defined as the
difference between the maximum (or minimum) value of the trace and
the mesor across a 24-h period [42]; changes in amplitude have
previously been proposed to provide an indication of the robustness of
the rhythm [39,43]. The phase represents the time at which the
temperature curve peaks, and basal for this dataset refers to the
baseline skin temperature recordings over the 48 h. These measures
represent the circadian parameters of the sinusoid fitting, which were
estimated by a nonlinear least-square method using the R package
minpack.lm [40]. We extracted the goodness-of-fit for the skin tem-
perature data by the coefficient of determination R2 ð0  R2  1Þ,
with R2 ¼ 1 indicating perfect sinusoid fitting, and R2 ¼ 0 indi-
cating no sinusoid fitting. The p-value of the sinusoid fitting was
examined by F-test [41].
After obtaining the diurnal parameters for each subject, we performed
statistical analysis of pre- vs. post-intervention values within each
group (NS or SR or SRþEX). Pre-post Amp , Basal , and R2 was
compared at pre-visit (day 2e3) and at post-visit (day 6e7). The p-
value for the pre-post comparison was obtained by a paired t-test,
which captured the repeated measurement from the same subject.
To examine changes from pre-post in the diurnal parameters across
intervention groups, linear mixed models were fit with subject specific
random intercept by R package lme4 [42], which accounts for the
within subject correlation. Specifically, one of the parameters (Amp ,
Basal or R2) was the outcome variable, intervention group, visit time
(pre [day 2e3] or post [day 6e7]), and their interaction were the
predictors. The p-value for the intervention interaction was used to
benchmark the significance level for how pre-post changes in the
circadian parameters differed by intervention group.
2.7. Oral glucose tolerance testing (OGTT)
To assess glucose tolerance, OGTT tests were performed on Day 3
(pre-intervention) and Day 8 (post-intervention) at 08:00 h, following
an overnight fast. Participants consumed a 300-mL solution containing
75 g of glucose (Point of Care Diagnostics-Scientific, NSW, Australia),
and blood samples were collected after 0, 10, 20, 30, 60, 90, and
120 min. Plasma glucose concentrations were measured on a glucose/
lactate analyzer (YSI, 2300 STAT plus, Yellow Spring, OH, USA).
Plasma insulin concentrations were assessed using an Insulin ELISA kit
(ALPCO. 80-INSHU-E01.1, E10.1, Salem, NH, USA) and run according
to the manufacturer’s instructions.
2.8. Muscle biopsies
One week prior to commencing the study, and on Day 3 and Day 8 of
the intervention, muscle biopsies were sampled from the vastus lat-
eralis muscle using a suction-modified Bergström needle, and under
local anesthesia of the skin and fascia (1% lidocaine). All samples were
collected at 10:00 h. Samples on Day 3 and 8 were collected post
OGTT. All samples were immediately frozen in liquid nitrogen and
stored at 80 C or set aside for mitochondrial respirometry.4 MOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. T2.9. High-resolution respirometry
Immediately following the muscle biopsies, muscle fibers were placed
in ice-cold biopsy preserving solution (BioPS) and prepared as previ-
ously described [26]. Mitochondrial respiration was measured in trip-
licate (coefficient of variation [CV]¼ 12%) (from 2 to 4 mg wet weight of
muscle fibers) in MiR05 at 37 C using the high-resolution Oxygraph-2k
(Oroboros, Innsbruck, Austria). Oxygen concentration (in nanomoles per
milliliter) and flux (in picomoles per second per milligram) were
recorded with DatLab software (Oroboros). The following substratee
uncouplereinhibitor titration (SUIT) protocol was used to assess
mitochondrial respiratory function; octanoyl-carnitine (0.2 mM) and
malate (2 mM) for leak respiration (L) via electron transferring flavo-
protein (ETF), (ETF)L, ADP (5 mM, saturating concentration) was added
for the measurement of oxidative phosphorylation capacity (P), (ETF)P.
Pyruvate (5 mM) was then added for measurement through Complex 1
(CI), (ETFþCI)P, followed by addition of succinate (10 mM) for the
measurement of oxidative phosphorylation capacity through complex 1
and 2 combined (ETFþCIþII)P. Cytochrome C (10 mM) was then added
to test for outer mitochondrial membrane integrity (an oxygen flux in-
crease of <15% from (ETFþCIþII)P was considered acceptable). A
series of stepwise carbonyl cyanide 4-(trifluoromethoxy) phenyl-
hydrazone (FCCP) titrations (0.75e1.5 mM) for the measurement of
ETS capacity (E) through (ETFþCIþII)E followed. Rotenone (0.5 mM), an
inhibitor of CI, was then added to determine E through CII (ETFþCII)E,
whereas the addition of antimycin A (2.5 mM), an inhibitor of CIII,
allowed to measure and correct residual oxygen consumption (ROX),
which is indicative of non-mitochondrial oxygen consumption. As there
was no difference in mitochondrial respiration between ‘Pre’ and Day 3
resting biopsies (mean (ETFþCIþII)P pmol O2.s1.mg1  SD; Pre e
81.4  21.6 pmol O2.s1.mg1, Day 3e80.6  21.0 pmol
O2.s
1.mg1, P ¼ 0.831), ‘Baseline’ mitochondrial respiration was
calculated as the mean from the ‘Pre’ study and Day 3 muscle biopsies.
2.10. Assessment of sarcoplasmic protein synthesis (SarcPS)
SarcPS was used as an indicator of mitochondrial protein synthesis
(MitoPS), as performed previously [24], due to the large amount of
muscle needed to assess MitoPS (e.g., 80e100 mg). In validating this
approach, we measured CS activity (a validated biomarker of mito-
chondrial content [16]) in whole-muscle lysate, as well as the myofi-
brillar and sarcoplasmic fractions (Figure 5A). The whole-muscle CS
activity was significantly higher than the myofibrillar fraction (mean
difference CS activity (mol/h/kg protein)  SD, 1.30  0.48, CI [0.64,
1.97], P < 0.001). The sarcoplasmic fraction CS activity was also
significantly higher than the myofibrillar fraction (2.05  0.35, CI
[-2.71, 1.39], P< 0.001) and whole-muscle fractions (0.74 0.44,
CI [-1.40, 0.07], P ¼ 0.027) demonstrating that the sarcoplasmic
fractions are enriched with mitochondria, compared to both the
myofibrillar fraction and whole-muscle sample.
To determine SarcPS, on Day 1, each participant ingested 150 mL of
deuterium oxide (D2O) (70 atom %, Cambridge Isotope Laboratories) as
previously described [43]. Saliva samples were collected prior to D2O
ingestion and then on Days 3, 5, 7, and 8 to determine body water
enrichment via cavity ring-down spectroscopy (Picarro L2130-I
analyzer, Picarro, Santa Clara, CA). Total body water 2H enrichment
was used as a surrogate for plasma alanine 2H labelling, as previously
described [43]. The mean body water enrichment (atom percent
excess, APE) has been reported previously [36].
Frozen muscle samples (40e60 mg) were homogenized and prepared
as previously described [44]. Cation exchange chromatography was
then performed on the sarcoplasmic samples using columns con-
taining Dowex resin (Dowex 50wx8-200 ion exchange resin, Sigmahis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Aldrich) to extract free amino acids from the sarcoplasmic fractions
[44]. The amino acid samples were then derivatized as their N-acetyl-
n-propyl-esters, as per previous protocols [45].
The 2H/1H ratio of the sarcoplasmic samples were determined using
gas chromatography pyrolysis isotope ratio mass spectrometry (GC-P-
IMS) (Metabolic Solutions, Nashua, NH, USA) to assess the incorpo-
ration of deuterium into protein-bound alanine. This was used to
assess the fractional synthetic rate (FSR) of sarcoplasmic proteins with
the use of the enrichment of body water, corrected for the mean
number of deuterium moieties incorporated per alanine (i.e., 3.7) as
previously described [43], as the surrogate precursor labelling be-
tween subsequent biopsies.
The following standard equation [43] was used to determine FSR:
FSR (%/day) ¼ ((Et1Et0)/(Ep  time))  100
where FSR ¼ fractional synthetic rate, Et1 ¼ APE Day 8, Et0 ¼ APE Day 3,
Ep ¼ average saliva APE, time ¼ time between biopsies, in days, and
APE ¼ atomic percentage excess.
2.11. Preparation of whole-muscle lysates for western blots and
CS activity assay
Frozen muscle (10e20 mg) was homogenized as previously described
[26] in an ice-cold lysis buffer (1:20 w/v) containing 50 mM of Tris,
150 mM of NaCl, 1 mM of EDTA, 1% IGEPAL, deionized water, and a
protease/phosphatase inhibitor cocktail (Cell Signaling Technology
(CST), Danvers, MA, USA), adjusted to pH 7.4. Protein concentration
was determined in triplicate with a commercial colorimetric assay
(Protein Assay kit-II; Bio-Rad, Gladesville, NSW, Australia) against
bovine serum albumin standards (BSA, A9647; Sigma-Aldrich).
2.12. Citrate synthase activity assay
Citrate synthase (CS) activity was determined in triplicate on a 96-well
microtiter plate by adding 7.5 mL of a 4 mg/mL muscle homogenate
(freeze-thawed in liquid nitrogen twice), 40 mL of 3 mM acetyl CoA,
25 mL of 1 mM 5,59-dithiobis(2-nitrobenzoic acid) (DTNB), and 165 mL
of 100 mM Tris buffer (pH 8.3, kept at 30 C). After addition of 15 mL of
10 mM oxaloacetic acid, the plate was immediately placed in an xMark-
Microplate spectrophotometer (Bio-Rad) at 30 C, and after 30 s of linear
agitation, absorbance at 412 nm was recorded every 15 s for 3 min. CS
activity is reported as moles per hour per kilogram of protein.
2.13. Western blotting
Muscle homogenate was diluted in 4X Laemmli buffer, and equal
amounts of total protein (15 or 20 mg) were loaded in different wells on
Criterion 4e20% TGX Stain-Free precast gels (Bio-Rad,
Australia). A stain-free system (Bio-Rad, Australia) was used as a
loading control, with protein expression normalized to total protein
loaded per lane (representative blot e Supplementary Figure 2). Each
gel also contained four to six internal standards of varying dilutions,
made from a mixed homogenate of every sample in equal concen-
trations. These standards were used to form a calibration curve, with
density plotted against protein content. Protein abundance was then
calculated from the measured band intensity for each sample on the
gel, using the linear regression equation from the calibration curve.
Muscle lysates were separated via gel electrophoresis and transferred
to polyvinylidene difluoride (PVDF) membranes. Membranes were then
blocked in 5% non-fat dry milk diluted in Tris-buffered saline with 0.1%
Tween-20 (TBST) for 60 min. Membranes were then incubatedMOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comovernight at 4 C with the appropriate primary antibody and prepared at
a 1:1,000 dilution in TBSTwith 5%BSA and 0.02% sodium azide (unless
stated otherwise). The following primary antibodies were from Cell
Signaling Technologies (CST) and include PGC-1a (CST2178), DRP1
(CST5341), MFN2 (CST9482), p53 (CST2527), GLUT4 (CST2213). The
following antibodies were obtained from Abcam, BMAL1 (AB93806) and
Total OXPHOS (AB110413). The membranes were then incubated at
room temperature with the appropriate host species-specific secondary
antibody for 60 min, before being exposed to a chemiluminescence
solution (Clarity Western ECL substrate [Bio-Rad, Hercules, CA, USA]
or SuperSignal West Femto Maximum Sensitivity substrate [Ther-
moFisher, ThermoFischer Scientific, Wilmington, DE, USA]). Images
were taken with a ChemiDoc Imaging System fitted (Bio-Rad). Densi-
tometry was performed with Image Lab 5.0 software (Bio-Rad). Images
are typically displayed with at least five bandwidths above and below the
band of interest.
2.14. Real-time quantitative polymerase chain reaction (qPCR)
RNA extraction with TRIzol (Life Technologies, 15596 026) from frozen
muscle samples (10e20 mg), quantification, and reverse transcription
(iScript Reverse transcription supermix, BioRad) were performed as
previously described [46]. Relative mRNA expression was measured by
qPCR (QuantStudio 7 Flex, Applied Biosystems, Foster City, CA) using
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad). Primers were
designed using Primer-BLAST to include all splice variants and were
purchased from Sigma-Aldrich (Supplementary Table 3). The expres-
sion of each target gene was normalized to the geometric mean of
expression of the three most stably expressed reference genes (as
previously described) [46] using the 2DDCt method (where Ct is the
quantification cycle). Because of insufficient muscle sample collections
for one participant, only samples from seven participants in the NS
group were prepared for RT-PCR.
2.15. Statistical analysis
Statistical analyses were conducted using the statistical software
package GraphPad Prism (V7.03). Pre- to post-intervention changes in
gene expression, protein content, mitochondrial respiratory function,
glucose tolerance, citrate synthase activity, and plasma insulin con-
centrations were assessed for each group using a mixed analysis of
variance (ANOVA) with one between-subjects measure (group) and a
within-subjects measure (time). Significant effects of interaction
(group time), time (pre vs post), and group (NS vs SR vs SRþEX) are
reported where effects are seen. Where significant interaction effects
occurred, Bonferonni post-hoc testing was performed to locate the
differences. Where appropriate, a Greenhouse-Geisser correction was
used to adjust for sphericity. All statistical analyses of gene expression
and protein content data were conducted using raw values. Gene
expression data in-text are reported as percent fold-changes from pre-
intervention values (mean %  SD) with 95% confidence intervals (CI)
from fold-change data (as a percentage), with the P value from the raw
data reported. Data in figures represent fold-changes from pre-
intervention values, with individual responses. A one-way ANOVA
was used to assess baseline differences between groups, mean values
for actigraphy and SarcPS throughout the intervention, and the mean
differences of changes from pre- to post-intervention between groups.
All data in text, figures and tables are presented as mean  standard
deviation (SD) and 95% confidence intervals, with P values  0.05
indicating statistical significance. Exact P values are presented unless
P < 0.001 or >0.999.access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
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3.1. Sleep data
To verify the efficacy of our sleep interventions, we measured the
participants’ total sleep time (TST) via actigraphy [34]. There was a
significant difference between groups (P < 0.001), with mean nightly
TST during the intervention significantly lower for the SR (mean dif-
ference for TST  SD min, 95% CI, P value, 220  8 min, CI [202,
237 min], P < 0.001) and SRþEX (214  8 min, CI [197, 232 min],
P < 0.001) groups compared to the NS group (Supplementary
Table 1). There was no difference in nightly TST between the SR
and SRþEX group (5  6 min, CI [-23, 12 min], P ¼ 0.718). Pol-
ysomnography (PSG), considered the gold standard assessment of
sleep [47], was used to confirm actigraphy TST data and to also assess
sleep architecture on night 6 of the study (n ¼ 4 per group)
(Supplementary Figure 1). Both the SR and SRþEX groups obtained
significantly less time in rapid eye movement (REM) sleep, non-rapid
eye movement (NREM) stage 1 sleep, and NREM stage 2 sleep,
compared to the NS group. Despite differences in TST between NS and
both the SR and SRþEX groups, there were no significant differences
in the absolute amount of sleep in the NREM stage 3 (N3) sleep be-
tween any of the groups (N3 sleep  SD, NS ¼ 72  17 min,
SR ¼ 75  18 min, SRþEX ¼ 71  14 min, P > 0.05)
(Supplementary Table 2). Thus, as reported previously [2], N3 sleep
was preserved despite the reduced total sleep time.
3.2. Wrist skin temperature analysis
Next, we used peripheral wrist skin temperature, obtained over two
48-h periods, pre- and post-intervention, to assess whether the sig-
nificant reduction in TST in the SR and SRþEX groups was associated
with changes in aspects of diurnal skin temperature rhythms, as
previously suggested [7,8]. To assess the robustness of the diurnal
skin temperature rhythms, we extracted the amplitude of the rhythms
and the coefficient of fit to a circadian wave pre-intervention and post-
intervention. We obtained basal temperature levels also to check for
any significant change in the range of temperatures among the groups.
As shown in Figure 2A, there were no differences observed in basal
skin temperature either pre- or post-intervention or between groups.
For wrist skin temperature diurnal amplitude, we observed significantly
diminished amplitude in both the SR (P ¼ 0.008) and SRþEX
(P ¼ 0.008) post-intervention results when compared to their pre-
intervention amplitude (Figure 2B). The difference between pre- and
post-intervention amplitude values for the SR group compared to the
NS group approached significance (P ¼ 0.055), but the pre-post
amplitude difference between the NS and the SRþEX group did not
(P ¼ 0.100). This finding suggests that the inclusion of exercise may
serve to help maintain diurnal amplitude in skin temperature (mean
amplitude change  SD C, 95% CI C; NS: -0.13  0.59 C, CI
[-0.37, 0.62 C]), SR: -0.74 0.57 C, CI [0.25, 1.22 C]) and SRþEX:
-0.60  0.47 C, CI [0.21, 0.99 C]) (Figure 2B). We also analyzed R2
(the coefficient of fit to the circadian wave form) as an assessment of
diurnal rhythm strength based on its similarity between pre- and post-
intervention. Similar to diurnal amplitude, we did not see a change in
R2 for the NS group, but did observe significantly decreased R2 when
comparing pre- and post-intervention values for SR (P ¼ 0.004) and
SRþEX (P ¼ 0.009). However, when assessing the change in R2
between groups we did not detect any differences (mean R2
change  SD, 95% CI; NS: -0.057  0.21, CI [-0.11, 0.23]; SR:
-0.20  0.13, CI [0.09, 0.31; SRþEX: -0.20  0.16, CI [0.07, 0.34]
(Figure 2C). Individual temperature traces for each subject both pre-6 MOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. Tand post-intervention can be found in the supplementary data
(Supplementary Figure 3).
3.3. Glucose tolerance
As sleep loss has been associated with impaired glucose tolerance, we
examined plasma glucose and insulin concentrations in response to an
OGTT, performed before and after the sleep interventions. There were
no significant differences between groups for pre-intervention glucose
(P¼ 0.771) and insulin (P¼ 0.137) area under the curve (AUC) values.
There was a significant change in total glucose AUC (interaction
P ¼ 0.002, day P ¼ 0.003, group P ¼ 0.100) from pre- to post-
intervention. Post-hoc analysis indicated that there was a significant
increase of total glucose AUC in the SR group (pre- and post-
intervention glucose AUC  SD, [95% CI of mean difference], P
value; pre: 678  92 vs post: 827  56 A.U., [54, 243 A.U.],
P¼ 0.002), but not the NS group (pre: 677 188 vs post: 617 136
A.U., [36, 154 A.U.], P¼ 0.356) or the SRþEX group (pre: 638 50
vs post: 705 71 A.U., [162 to 28 A.U.], P¼ 0.239). There was also
a significant difference between groups for mean change in glucose
AUC from pre- to post-intervention (P¼ 0.002), with post-hoc analysis
indicating that the mean change for the SR group was significantly
different from the mean change for the NS group (mean change
difference  SD for NS vs SR; 208 168, [74, 342 A.U.], P ¼ 0.002).
However, there were no differences in the mean change for glucose
AUC between NS and SRþEX (126 135 A.U., [8, 260], P¼ 0.069)
or SR and SRþEX (81  129 A.U., [216, 52], P ¼ 0.381). There
was no significant change (interaction P ¼ 0.085, day P ¼ 0.225,
group P ¼ 0.130) in insulin AUC within any group pre- to post-
intervention, despite a 29% increase in mean insulin AUC following
the SR intervention (NS pre: 5,845  3,548 vs post: 5,264  2,072
A.U., CI [2,037, 874 A.U.]; SR pre: 4,454  2,233 vs post:
5,729  1,983 A.U., CI [180, 2,731 A.U.]; and SRþEX pre:
3,095  1,766 vs post: 3,614  1,854 A.U., CI [937, 1,975 A.U.])
(Figure 3 and Supplementary Tables 6 and 7). There were also no
between-group differences for insulin AUC mean change (P ¼ 0.085).
3.4. Mitochondrial content, function, and protein synthesis
As both insulin resistance and reduced glucose tolerance have been
linked to changes in mitochondrial characteristics, we investigated
whether skeletal muscle mitochondrial respiratory function, content,
and protein synthesis (via sarcoplasmic protein synthesis) were
influenced by the sleep loss and exercise interventions. There were no
significant differences between groups for pre-intervention mito-
chondrial respiration (P ¼ 0.691). There was a significant change for
maximal coupled mitochondrial respiration (ETFþCIþCII)P (interaction
P ¼ 0.032, time P ¼ 0.001, group P ¼ 0.960), which revealed a
reduction from pre- to post-intervention in the SR group (pre: vs post
mean value  SD pmol O2.s1.mg1, [95% CI for change], P value) in
the SR group (pre: vs post: 88.4  24.6 vs post: 72.5  22.6 pmol
O2.s
1.mg1, CI [25.6, 6.1 pmol O2.s1.mg1], P ¼ 0.001) (18%
decrease and a coefficient of variation (CV) of 12%) (Figure 4A). This
was not evident in the NS (pre: 80.8 14.0 vs post: 72.7 19.6 pmol
O2.s
1.mg1, CI [1.6 to 17.9 pmol O2.s1.mg1], P ¼ 0.122) or
SRþEX groups (pre: 81.2  18.7 vs post: 80.5  24.0 pmol
O2.s
1.mg1, CI [9.1, 10.4 pmol O2.s1.mg1], P ¼ 0.997). There
were also between-group differences for mean change in respiration
between pre- and post-intervention (P ¼ 0.032), with post hoc anal-
ysis indicating a difference between the mean change in respiration for
SR, compared to SRþEX (SR vs SRþEX mean change
difference  SD, 15.2  17.1 pmol O2.s1.mg1, [1.3, 29.1 pmolhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Measures of diurnal peripheral skin temperature A) basal skin temperature, B) amplitude, and C) coefficient of fit (R2) pre- and post-intervention. Pre-
intervention measurements are Day 2 and 3 (until 23:00 h) and the post-intervention measurements are Day 6 and Day 7. Normal Sleep (NS, n ¼ 8), Sleep Restriction (SR,
n ¼ 8), and Sleep Restriction and Exercise (SRþEX, n ¼ 8). * Denotes significant within-group differences from pre- to post-intervention (P < 0.05).O2.s
1.mg1], P ¼ 0.029), but not NS and SR (7.7  14.2 pmol
O2.s
1.mg1, [21.6, 6.2 pmol O2.s1.mg1], P ¼ 0.488) or NS and
SRþEX (7.5  13.7 pmol O2.s1.mg1, [-6.4, 21.3 pmol
O2.s
1.mg1], P ¼ 0.528). These results show for the first time that
sleep loss is associated with decreased mitochondrial respiratory
function, which was not observed in the SRþEX group.
Mitochondrial content can be assessed by CS activity and the protein
content of mitochondrial complex subunits [16]. There were no
changes in whole-muscle CS activity from pre- to post-intervention for
any of the groups (interaction, P ¼ 0.972, time P ¼ 0.176, group
P ¼ 0.944) (mean value  SD, 95% CI, P value, NS pre: 2.81  1.00
vs post: 2.71  1.22 mol/h/kg protein, CI [-0.24, 0.44 mol/h/kg
protein]); (SR pre: 2.82  0.56 vs post: 2.69  0.62 mol/h/kg protein,
CI [-0.21, 0.47 mol/h/kg protein]) and (SRþEX pre: 2.69  0.47 vs
post: 2.60  0.65 mol/h/kg protein, CI [-0.26, 0.43 mol/h/kg protein])
(Figure 4D). There were also no between-group differences for mean
change of CS activity (P¼ 0.917). As a further validation of changes in
mitochondrial content, the protein content for subunits of mitochondrial
complexes were assessed via western blotting. No significant main
effects were observed for the protein content of Complex 1, Complex 2,
Complex 3, Complex 4, or Complex 5 (Figure 4E), collectively indicating
that the sleep and exercise interventions did not affect mitochondrial
content.
It has been argued that the best measure of mitochondrial biogenesis is
mitochondrial protein synthesis (MitoPS) [48]. The sarcoplasm (skeletalMOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.commuscle cytoplasm) is enriched with mitochondria (see Figure 5A), and
protein synthesis within this fraction (sarcoplasmic protein synthesis -
SarcPS) is likely reflective ofMitoPS [24]. Therefore, for the first time, we
assessed the effects of sleep restriction on SarcPS, which indicated that
there was a significant difference between groups for fractional syn-
thetic rate (FSR) (P < 0.001), with post-hoc testing indicating that FSR
was significantly lower in the SR group compared to both the NS group
(between groups difference FSR %/day  SD, 95% CI, P
value,0.62 0.11%, CI [-0.90,0.33], P< 0.001) and the SRþEX
group (0.66  0.12%, CI [-0.95, 0.37], P < 0.001); there was no
difference in SarcPS between the NS and SRþEX groups
(0.04 0.10%, CI [-0.33, 0.24], P> 0.999) (Figure 5B). This new data
suggest that participants in the SRþEX group maintained higher levels
of SarcPS than those in the SR group.
3.5. Glucose, circadian, and mitochondrial-related gene expression
and protein content
Given the changes observed for mitochondrial respiration, protein
synthesis, circadian rhythm (in previous sleep studies [7,8]), and
glucose tolerance, we investigated the expression of genes that
regulate these processes (full list available in Table 2). With the
remaining muscle biopsy tissue, we also assessed the content of
proteins related to mitochondrial, circadian, and glucose-regulating
processes. However, there were no significant differences within
groups from pre- to post-intervention, or between groups (P > 0.05)access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 7
Figure 3: Plasma glucose and insulin concentrations for pre- and post-intervention oral glucose tolerance tests (OGTT). Plasma glucose and insulin concentrations
throughout the 120-minute OGTT in the (A, B) Normal Sleep (NS), (C, D) Sleep Restriction (SR), and (E, F) Sleep Restriction and Exercise (SRþEX) groups. G) glucose and H) insulin
total area under the curve (AUC) during the OGTT. Values are mean SD, individual data points are shown, * Denotes significant within-group differences from pre- to post-
intervention (P < 0.05). # Denotes significant between group difference for the change from pre- to post-intervention compared to the NS group (P < 0.05). n ¼ 8 per group.
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Figure 4: Mitochondrial respiratory function and markers of mitochondrial content from pre-intervention compared to post-intervention. A) Mitochondrial respiratory
function in the Normal Sleep (NS), Sleep Restriction (SR), and Sleep Restriction and Exercise (SRþEX) groups. (B) Citrate synthase activity and (C) fold-change of protein content for
subunits of mitochondrial complexes (IeV) from pre- to post-intervention. Mitochondrial complex 1 (CI) - NDUFB8, Complex 2 (CII) - SDHB, Complex 3 (CIII) - Core protein 2
(UQCCRC2), Complex 4 (CIV) e MTCO, and Complex 5 (CV) e ATP5A. (D) Representative image of protein content for mitochondrial complexes. (ETFþCIþCII)P- maximal coupled
mitochondrial respiration through ETF, CI and CII; Pre e pre-intervention, Post e post-intervention. n ¼ 8 per group. * Denotes significant difference within group from pre- to
post-intervention (P < 0.05). d Denotes significant between group difference, for the change from pre- to post-intervention compared to the SRþEX group (P < 0.05).for PGC-1a, DRP1, MFN2, p53, BMAL1, or GLUT4 protein content
(Figure 6).
4. DISCUSSION
We discovered that in healthy young men, sleep restriction resulted in
significantly impaired glucose tolerance, with concomitant changes in
skeletal muscle mitochondrial respiratory function, sarcoplasmic pro-
tein synthesis (SarcPS) e a proxy for mitochondrial protein synthesis,
and diurnal rhythms of peripheral skin temperature. However, in those
performing three sessions of high-intensity interval exercise (HIIE)
during the sleep restriction intervention, these same perturbations
were not observed. Our study provides novel insights into the potential
mechanisms underlying previously reported changes in glucose
tolerance with sleep loss and suggests exercise may be used as a
therapeutic intervention to attenuate such adverse effects.
The sleep restriction protocol used in this study (consisting of 4 h TIB
per night, for five consecutive nights) resulted in a significant
impairment in glucose tolerance. Furthermore, the plasma insulin
response during the OGTT for the SR group increased by 29% from
pre- to post-intervention (although not statistically significant). These
results are consistent with previous studies [3e5], including Rao et al.
[2] who reported a 25% decrease in whole-body insulin sensitivityMOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.com(measured with a hyperinsulinemic-euglycemic clamp) following a
similar sleep restriction protocol [2]. Therefore, the 22% increase in
plasma glucose AUC following sleep restriction observed in young,
healthy men in this study solidifies the evidence supporting the
detrimental effect of even short periods of sleep restriction on glucose
tolerance.
A novel aspect of this study was to examine the effect of three sessions
of HIIE during the period of sleep restriction as a means of mitigating
sleep restriction-induced reductions in glucose tolerance. In contrast to
the SR group, adverse changes in glucose tolerance were not observed
in the SRþEX group. While others have shown acute positive [49] and
protective [50] effects of exercise on sleep-loss-induced changes in
glucose tolerance, these studies assessed glucose tolerance either
immediately after or within 24 h of exercise. This raises the possibility
that these findings were confounded by the acute effects of exercise on
glycemic control, which are known to persist for up to 48 h [22]. In
contrast, we performed the OGTT 48 h post-exercise, thus demon-
strating for the first time that the negative effects of sleep loss on
glucose tolerance were not observed when performing HIIE during a
period of sleep restriction.
At the molecular level, we reported a 33% change in Glut4 mRNA (that
was not statistically significant) in the SR group, with no change in
GLUT4 protein. Our findings mirror those from Cedernaes et al. [8],access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 9
Figure 5: Citrate synthase (CS) activity from fractionated skeletal muscle samples and sarcoplasmic protein synthesis (SarcPS) e A) CS activity of whole-muscle lysate
(Total), myofibrillar (Myo), and sarcoplasmic (Sarc) fractions were assessed from the same muscle samples (n ¼ 5). B) Fractional synthetic rate (FSR) of SarcPS during the sleep
intervention. Data are mean  SD. Normal Sleep (NS), Sleep Restriction (SR), and Sleep Restriction þ Exercise (SRþEX), n ¼ 8 per group. * Denotes significantly different from
other groups (P < 0.05).
Original Articlewho reported no significant change in Glut4 mRNA or GLUT4 protein
following one night of total sleep deprivation. While exercise is known
to acutely increase skeletal muscle Glut4 mRNA [22], we did not
observe an increase in the SRþEX group. This may be explained by the
timing of our muscle sample, which was collected 48 h post the final
exercise session, by which time Glut4 mRNA expression may have
returned to baseline levels [22,51]. Therefore, while no changes to
Glut4 mRNA or protein content were observed in tandem with changes
in glucose tolerance, it is plausible that GLUT4 translocation to the cell
membrane may be impaired, which would support previous research
that has indicated impairments within the insulin signaling pathway
following sleep restriction [52,53].
Insulin resistance and reductions in glucose tolerance have previously
been linked to altered mitochondrial characteristics [14,15,54];
therefore, we also assessed changes in skeletal muscle mitochondrialTable 2 e Glucose, circadian, and mitochondrial-related skeletal muscle mRNA
Name NS SR SRþEX
Glucose metabolism-related mRNA
Glut4 14  18 38  33 16  83
Ampk1a 17  30 1  52 15  24
Pdk4 0  105 124  286 60  111
b-Had 30  42 25  39 15  42
Circadian-related mRNA
Bmal1 2  22 29  33 7  51
Clock 6  75 7  45 14  37
Per1 7  44 28  48 2  71
Per2 4  32 7  51 6 48
Cry1 7  45 12  34 10  21
Rev-Erb a 9  38 9  47 20  42
Mitochondrial-related mRNA
Pgc1a 33  51 23  49 14  61
p53 48  58 89  100 6  41
Tfam 20  33 22  41 7  59
Nrf2 1  34 11  33 4  43
Dnm1l 14  45 3  65 4  72
Mfn1 6  39 12  47 5  53
Mfn2 18  28 35  28 2  68
Lc3b 4  50 16  40 11  55
p62 39  75 1  39 8  69
Pink1 21  34 32  45 2  74
Cox4 11  22 23  28 3  65
Values are mean SD percent (%) changes from pre-intervention mRNA values. Normal Slee
n ¼ 8). Significant main effects (P < 0.05) are highlighted in bold. * Denotes significantly
10 MOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. Trespiratory function. To our knowledge, our study is the first report of
an SR-induced reductions in skeletal muscle mitochondrial respiratory
function in humans. Previously, a study in humans investigating a
single night of 4 h TIB reported a decrease in insulin sensitivity with a
concomitant increase in plasma acylcarnitines [9], which was sug-
gested to be indicative of both reduced fatty acid oxidation and
impaired mitochondrial function. The maintenance of mitochondrial
respiratory function in the SRþEX group is consistent with previous
reports of the potency of HIIE for improving mitochondrial respiratory
function [26,55]; however, we do not have a Normal Sleep and HIIE
group that would allow us to ascertain whether HIIE enhanced mito-
chondrial function. Nonetheless, our results do provide evidence
supportive of a link between reduced mitochondrial respiratory func-
tion and impaired glucose tolerance, which was not observed in the
SRþEX group.responses.
Interaction effect Time effect Group effect
P ¼ 0.192 P [ 0.022 P¼0.988
P ¼ 0.952 P ¼ 0.060 P¼0.334
P ¼ 0.862 P ¼ 0.850 P¼0.995
P ¼ 0.872 P [ 0.011 P¼0.547
P ¼ 0.154 P [ 0.041 P¼0.319
P ¼ 0.775 P ¼ 0.407 P¼0.189
P ¼ 0.527 P ¼ 0.123 P¼0.853
P ¼ 0.719 P ¼ 0.410 P¼0.653
P ¼ 0.466 P ¼ 0.982 P¼0.466
P ¼ 0.583 P ¼ 0.130 P¼0.231
P ¼ 0.552 P ¼ 0.076 P¼0.162
P ¼ 0.523 P ¼ 0.067 P¼0.552
P ¼ 0.816 P ¼ 0.035 P¼0.806
P ¼ 0.777 P ¼ 0.179 P¼0.309
P ¼ 0.937 P ¼ 0.170 P¼0.625
P ¼ 0.414 P ¼ 0.524 P¼0.791
P ¼ 0.562 P [ 0.002 P¼0.901
P ¼ 0.486 P ¼ 0.177 P¼0.244
P ¼ 0.088 P ¼ 0.628 P¼0.096
P ¼ 0.895 P ¼ 0.204 P¼0.784
P ¼ 0.537 P ¼ 0.088 P¼0.609
p (NS, n¼ 7), Sleep Restriction (SR, n¼ 8), and Sleep Restriction and Exercise (SRþEX,
different from pre-intervention value (P < 0.05).
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 6: Skeletal muscle mitochondrial-, circadian-, and glucose-related protein content A) PGC-1a, B) DRP1, C) MFN2, D) p53, E) BMAL1, F) GLUT4, and G) repre-
sentative western blot images. Data are mean values  SD, normalized to pre-intervention values. Normal Sleep (NS), Sleep Restriction (SR) and Sleep Restriction and Exercise
(SRþEX), n ¼ 8 per group. * Denotes significant change from pre-intervention (P < 0.05).Mitochondria are dynamic organelles, and the production of new
mitochondrial proteins is an important determinant of their overall
function [48]. Mitochondrial protein synthesis (MitoPS) is the measure
that best reflects the process of mitochondrial biogenesis [23,48].
However, tissue availability for this project necessitated the use of
sarcoplasmic protein synthetic rate (e.g., SarcPS e Figure 5A) as a
proxy for MitoPS. For the first time, we report a lower rate of SarcPS in
the SR group compared to both the NS and SRþEX groups (Figure 5B).
The significance of the lower rate of SarcPS in the SR group is difficult
to ascertain; however, we hypothesizes that it may underpin a reduced
turnover of mitochondrial proteins, with a subsequent impact on
mitochondrial respiratory function [48]. Support for this notion comes
from the observation that changes in MitoPS and mitochondrial res-
piratory function have been shown to occur concomitantly [23,56];
nonetheless, a direct link is yet to be established. Moreover, HIIE has
consistently been reported to increase both SarcPS and MitoPS
[24,57], and this likely accounts for the higher rate of SarcPS in the
SRþEX group compared to the SR group. Indeed, previous reports
indicate that SarcPS remains elevated for 48 h following endurance
exercise [58], and these increases are likely reflected in the integrative
measure of protein synthesis used in this study, which represents a
summation of SarcPS throughout the entire intervention.
Considering the changes observed to SarcPS, the effect of sleep re-
striction on markers of mitochondrial content was also assessed.
There were no changes to the protein content of mitochondrial complex
subunits or CS activity, both of which are valid markers of mito-
chondrial content [16]. While reduced CS activity has previously been
reported following sleep interventions, this was in response to extreme
sleep deprivation (i.e., 120 h of continuous wakefulness) [18]; thus, a
direct comparison with our findings is difficult. Despite no change in CS
activity or protein content of mitochondrial complex subunits in the
SRþEX group, endurance exercise is well known to increase mito-
chondrial content [25]. Our results suggest changes in mitochondrial
respiratory function and SarcPS occurred independently of detectable
changes in mitochondrial content. This dissociation between changes
in mitochondrial content and respiratory function has previously beenMOLECULAR METABOLISM 43 (2021) 101110  2020 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comreported, and it has been suggested that these properties may be
differentially regulated [26,56]. One explanation for our observations
may involve the processes regulating mitochondrial dynamics/
remodeling (i.e., fission and fusion), which can alter the efficiency and
oxidative capacity of the mitochondria, without necessarily altering
mitochondrial content [23]. Therefore, we assessed genes and pro-
teins known to be central to the regulation of mitochondrial remodeling
(e.g., fission - Drp1, and fusion e Mfn1/2) [59]. However, despite a
non-significant 35  28% change in Mfn2 mRNA in the SR group, we
observed no changes in the molecular regulators of mitochondrial
dynamics. Considering that exercise can also acutely influence
markers of mitochondrial dynamics [59], this suggests the chosen
muscle sampling time points may not have been appropriate to detect
these potential changes [51].
As many of the molecular processes that regulate mitochondrial con-
tent, function, and dynamics are regulated in a circadianmanner [60,61]
and considering that molecular markers of circadian rhythm are altered
by a night of sleep deprivation [7,8], we also examined aspects of diurnal
rhythmicity using themeasures of peripheral skin temperature (obtained
over 48 h, pre- and post-intervention) and analysis of molecular clock
gene expression. Peripheral skin temperature measures oscillate
inversely to the rhythms of core body temperature, and therefore pro-
vides a physiological index of circadian output. We show that the
amplitude of the temperature rhythms decreased significantly in both SR
and SRþEX when compared to pre-intervention values. This is
consistent with previous human studies demonstrating diminished
temperature amplitude in other populations with disrupted sleep
including shift work, metabolic syndrome, and sleep-disordered
breathing [62e64]. In fact, similar to our study, Martinez-Nicolas
et al. [63] demonstrated improved circadian temperature amplitude in
response to a continuous positive airway pressure (CPAP) intervention,
which suggests that physiological interventions can mitigate some
circadian aspects of sleep disruption. Previously, Moller-Levet et al. [65]
reported reduced amplitude of circadian expression of core clock genes
following seven nights of sleep restriction (6 h TIB each night), in human
white blood cells. However, at the skeletal muscle level, we did not seeaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 11
Original Articleany changes in circadian clock genes (despite a 29 33%, reduction in
Bmal1 mRNA in the SR group). This is in contrast to previous findings
from Cedernaes et al. [7,8] who reported a decrease in Bmal1 mRNA
expression in 15 participants following 24 h of sleep deprivation. This is
potentially explained by the differences in length and severity of the
sleep loss interventions and/or the difference in participant numbers and
statistical power. We also report no alteration in skeletal muscle Bmal1
mRNA in the SRþEX group. While others have reported exercise-
induced changes in skeletal muscle clock gene expression [32,66],
this is thought to be a time-of-day dependent effect [66]. Whether
performing exercise at alternate times of the day might influence clock
gene expression in human skeletal muscle differently remains to be
elucidated. Considering the negative metabolic consequences, such as
reduction in insulin sensitivity and mitochondrial function, attributed to
both circadian misalignment and sleep loss [21,67] and the potential
benefits of exercise in this context [17,68], further research is
warranted.
This study has some limitations. Because of the extremely challenging
and invasive nature of the protocol, a parallel group design was
chosen. To offset the challenges associated with such designs for
comparing results between groups, we adopted an approach that
allowed us to closely match the groups for baseline characteristics
(Table 1). Further, it is also important to note that muscle samples
were collected following an OGTT to minimize any potential effect
caused by the biopsy procedure on the participant’s glycemic
response. This may have altered molecular signaling pathways,
although we did not observe any differences between the groups.
Finally, the inclusion of a normal sleep and exercise group (NSþEX),
would have helped to elucidate the contribution of HIIE to prevent the
negative metabolic consequences observed in the SR group.
In summary, we have provided the first direct evidence of a
concomitant decrease in mitochondrial respiratory function, SarcPS (of
which MitoPS is a contributor), diurnal rhythms, and glucose tolerance,
following sleep restriction in otherwise healthy young men. Despite
this, we did not observe any alterations in mRNA or protein content
associated with the regulation of these processes. Collectively, these
results highlight several potential mechanisms by which sleep re-
striction may lead to reduction in glucose tolerance. Importantly, these
same detrimental effects to mitochondrial function and SarcPS were
not observed when HIIE was performed during the period of sleep
restriction. While further research is still required, these data provide a
basis for the development of evidence-based health guidelines and
recommendations for those experiencing inadequate sleep by high-
lighting some of the underlying biological mechanisms that can be
targeted by therapeutic interventions such as exercise.
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